Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Korea Investment Partners
AddedFeb 13, 2024
UpdatedJul 16, 2026
Korea Investment Partners

Korea Investment Partners

Operating

Korea Investment Partners: A venture capital firm specializing in equity investments across diverse sectors in South Korea.

Location
Seoul, Seoul, KR
Founded
1986
Firm
Compare
Portfolio
Employees
News

Korea Investment Partners Co., Ltd. provides equity investment services.

The Company operates investment businesses in consumer internet, semiconductor equipments, biological technology, and other area. Korea Investment Partners conducts businesses in South Korea.

Korea Investment Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments48
Current Portfolio Count36
Total Portfolio Exits2

Top Investment Stages

Series B15 (36.6%)
Series A13 (31.7%)
Seed5 (12.2%)
Series C4 (9.8%)
Series Unknown4 (9.8%)

Stage Mix

Series B 37%Series A 32%Seed 12%Series C 10%Series Unknown 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Twelve Labs logo

Twelve Labs

Jenfi logo

Jenfi

Vedanta Biosciences logo

Vedanta Biosciences

Timely Technology logo

Timely Technology

Rgenta Therapeutics logo

Rgenta Therapeutics

Apposter logo

Apposter

CashWalk logo

CashWalk

Geneos Therapeutics logo

Geneos Therapeutics

Adriel logo

Adriel

Rizzle logo

Rizzle

Pavilion Data Systems logo

Pavilion Data Systems

Spatial logo

Spatial

OncoMyx Therapeutics logo

OncoMyx Therapeutics

Viron logo

Viron

GenEdit logo

GenEdit

Tribe logo

Tribe

Evos Esports logo

Evos Esports

Machbase logo

Machbase

QuotaBook logo

QuotaBook

Actym Therapeutics logo

Actym Therapeutics

Ansun Biopharma logo

Ansun Biopharma

Gushcloud logo

Gushcloud

Inovio Pharmaceuticals logo

Inovio Pharmaceuticals

OncXerna Therapeutics logo

OncXerna Therapeutics

Simplex logo

Simplex

Korea Investment Partners - Similar Investment Firms

Korea Investment Private Equity logo

Korea Investment Private Equity

Seoul Investment Partners Co logo

Seoul Investment Partners Co

Company K Partners logo

Company K Partners

KB Investment logo

KB Investment

kbic.co.kr

Kona Venture Partners logo

Kona Venture Partners

Korea Venture Investment logo

Korea Venture Investment

Korea Growth Investment logo

Korea Growth Investment

kgrowth.or.kr

E&Investment logo

E&Investment

Intervalue Partners logo

Intervalue Partners

intervaluep.com

KIH logo

KIH

koreaholdings.com

Premier Partners logo

Premier Partners

Kolon Investment logo

Kolon Investment

Korea Omega Investment logo

Korea Omega Investment

Hi Investment Partners logo

Hi Investment Partners

SBI Investment Korea Co logo

SBI Investment Korea Co

sbik.co.kr

Korea Investment Partners - Classification

Also Known As
  • Korea Investment Partners Co., Ltd
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end